Heads Of Israel’s Perrigo Called To Testify At Hearing On Thyroid Drug
This article was originally published in PharmAsia News
Executive Summary
Executives of Israel’s Perrigo have been summoned to a hearing by the Health Ministry in an investigation into side-effects of the firm’s Eltroxin (levothyroxine) to threat thyroids.